XRAY vs COO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

XRAY

42.7
AI Score
VS
COO Wins

COO

45.9
AI Score

Investment Advisor Scores

XRAY

43score
Recommendation
HOLD

COO

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY COO Winner
Forward P/E 7.2359 13.1926 XRAY
PEG Ratio 0.7238 0.6055 COO
Revenue Growth -4.1% 0.6% COO
Earnings Growth 15.2% 357.1% COO
Tradestie Score 42.7/100 45.9/100 COO
Profit Margin -15.0% 13.5% COO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: +14.8% · 3M: -15.7% COO 1M: +15.3% · 3M: -17.8%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $9.76

COO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.1 · Price: $62.93

Fundamentals Snapshot

Metric XRAY COO
Market Cap — —
Forward P/E 7.8 13.4
Trailing P/E — 21.8
Revenue (TTM) — —
Revenue Growth -0.1% 0.0%
Gross Margin 0.5% 0.7%
Operating Margin 0.0% 0.2%
EPS -0.61 2.91
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, COO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.